Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety, Efficacy and PK of Ronkyla Plus for Superficial Lipoma
NCT07237425Phase 1Recruiting
- Sponsor
- Glonova Limited
- Start
- Nov 2025
- Primary completion
- May 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of Ronkyla Plus in lipoma and submental fullness, sponsored by Glonova Limited. Started Nov 2025; status: recruiting.
02
Drugs
Ronkyla Plus
03
Conditions
lipomasubmental fullness
Beyond the preview
Go deeper on NCT07237425.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07237425.